SecBot SecBot
Insider Cluster (2 insiders) ·Filed Apr 9, 2026

GLUE

Monte Rosa Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $245K total
Actionable Insight • Neutral

The selling is minimal relative to company size and appears routine; no immediate red flag for traders, but monitor for further selling in upcoming weeks, especially ahead of potential catalysts.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
GLUE ▲ +28.81% at T+60d
NEUTRAL call +28.81% · α vs SPY +18.03% · entry $18.05 → $23.25
Entry = T+0 close
Apr 8, 2026
via day close
T+1d
-3.16%
call -3.16% · α -3.10%
$17.48
settled 7mo ago
T+5d
+3.60%
call +3.60% · α +0.42%
$18.70
settled 7mo ago
T+20d
+12.96%
call +12.96% · α +5.40%
$20.39
settled 6mo ago
T+60d
+28.81%
call +28.81% · α +18.03%
$23.25
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at Monte Rosa Therapeutics sold shares in the past week, including CEO Markus Warmuth selling $141K and Chief Business & Legal Officer Philip Nickson selling $103K, totaling $245K in open-market transactions. This represents less than 0.1% of the company's $1.4B market cap, indicating routine, non-material insider selling.

Key Financial Metrics

Direction
selling
Total Value
$244.5K
Insiders
2

Key Facts

  • CEO Markus Warmuth sold 8,000 shares at $17.64, totaling $141,124 on 2026-04-14
  • Chief Business & Legal Officer Philip Nickson sold 5,845 shares at $17.69, totaling $103,413 on 2026-04-09
  • Total value of insider sales: $245K over a 7-day window
  • All transactions were open-market sales (Form 4 code 'S')
  • Combined sales represent approximately 0.0175% of the $1.4B market cap

Financial Impact

$245,000 in total open-market sales

insider ownershipshare float

Risk Factors

  • Perception of insider lack of confidence if selling continues
  • Potential for increased scrutiny if earnings or clinical data are upcoming

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GLUE-1776283537016
19 reports for GLUE
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 3 of 4 best @ T+60▲ +18.17%Apr 20, 2026
Filters
Rows
Reports for GLUE — sortable, filterable
TypeNow
Oct 1, 2026
26d ago
8-K
BULLISH ★ 7/10
$11.26awaiting T+60—$10.48 (−6.93%)
Sep 30, 2026
26d ago
Press Release
NEUTRAL ★ 5/10
$11.26awaiting T+60—$10.48 (−6.93%)
Aug 6, 2026
11w ago
8-K
NEUTRAL ★ 5/10
$15.71awaiting T+60—$10.48 (−33.29%)
Jul 17, 2026
14w ago
Insider Cluster
NEUTRAL ★ 2/10
$23.48 $9.89▼ −57.88%▼ −62.72%$10.48 (−55.37%)
Jul 7, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.06 $11.93▼ −50.42%▼ −52.73%$10.48 (−56.44%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.21 $11.72▼ −51.59%▼ −54.60%$10.48 (−56.71%)
Jul 1, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.21 $11.72▼ −51.59%▼ −54.60%$10.48 (−56.71%)
Jun 29, 2026
17w ago
144
NEUTRAL ★ 2/10
$24.20 $11.89▼ −50.87%▼ −54.43%$10.48 (−56.69%)
Jun 25, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$22.29 $12.60▼ −43.47%▼ −49.56%$10.48 (−52.98%)
Jun 2, 2026
20w ago
Insider Cluster
NEUTRAL ★ 3/10
$17.59 $14.32▼ −18.59%▼ −21.09%$10.48 (−40.42%)
Showing 10 of 19

US Market Status

Market Closed — Opens in 23m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 15, 2026